Min YJ - Search Results

1

Anorectal and gastric peripheral T-cell lymphoma, unspecified in a non-AIDS patient.

Eum EA, Kim H, Kim YM, Woo SJ, Cho JH, Min YJ, Park JH. Eum EA, et al. Among authors: min yj. Korean J Intern Med. 2006 Dec;21(4):262-5. doi: 10.3904/kjim.2006.21.4.262. Korean J Intern Med. 2006. PMID: 17249511 Free PMC article.

2

Gemcitabine therapy in patients with advanced pancreatic cancer.

Min YJ, Joo KR, Park NH, Yun TK, Nah YW, Nam CW, Park JH. Min YJ, et al. Korean J Intern Med. 2002 Dec;17(4):259-62. doi: 10.3904/kjim.2002.17.4.259. Korean J Intern Med. 2002. PMID: 12647642 Free PMC article.

3

A less intensive combination of paclitaxel and carboplatin in advanced non-small cell lung cancer patients who have aged 60 years or more and has a poor performance status.

Min YJ, Ahn JJ, Noh YJ, Cha HJ, Suh JH, Jung JP, Park CR, Jeong AK, Park JH, Lee KM. Min YJ, et al. Korean J Intern Med. 2004 Jun;19(2):109-13. doi: 10.3904/kjim.2004.19.2.109. Korean J Intern Med. 2004. PMID: 15366642 Free PMC article.

4

A phase II study of docetaxel and cisplatin in patients with gastric cancer recurring after or progressing during 5-FU/platinum treatment.

Kim H, Park JH, Bang SJ, Kim DH, Cho HR, Kim GY, Min YJ. Kim H, et al. Among authors: min yj. Jpn J Clin Oncol. 2005 Dec;35(12):727-32. doi: 10.1093/jjco/hyi199. Epub 2005 Dec 6. Jpn J Clin Oncol. 2005. PMID: 16332720 Clinical Trial.

5

Granulocyte function is stimulated by a novel hexapeptide, WKYMVm, in chemotherapy-treated cancer patients.

Kim H, Park JH, Lee EH, Kim MJ, Park SK, Heo SK, Kim BS, Min YJ. Kim H, et al. Among authors: min yj. Exp Hematol. 2006 Apr;34(4):407-13. doi: 10.1016/j.exphem.2006.01.010. Exp Hematol. 2006. PMID: 16569587 Free article. Clinical Trial.

6

Enhanced bactericidal function by WKYMVm in patients with acute leukemia.

Kim H, Noh EK, Lee EJ, Baek JH, Shin SJ, Park JH, Lee KH, Min YJ. Kim H, et al. Among authors: min yj. Leuk Res. 2008 May;32(5):717-25. doi: 10.1016/j.leukres.2007.09.006. Epub 2007 Oct 24. Leuk Res. 2008. PMID: 17950844

7

Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.

Shin SJ, Kim H, Baek JH, Ahn JJ, Jegal Y, Seo KW, Park CR, Shin JK, Jung JP, Kim JW, Cha HJ, Kwon WJ, Jeong AK, Noh YJ, Park JH, Min YJ. Shin SJ, et al. Among authors: min yj. Lung Cancer. 2008 Apr;60(1):83-91. doi: 10.1016/j.lungcan.2007.09.013. Epub 2007 Nov 14. Lung Cancer. 2008. PMID: 18006180 Clinical Trial.

8

Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: a phase II study.

Kim H, Park JH, Shin SJ, Kim MJ, Bang SJ, Park NH, Nah YW, Nam CW, Joo KR, Min YJ. Kim H, et al. Among authors: min yj. Chemotherapy. 2008;54(1):54-62. doi: 10.1159/000112417. Epub 2007 Dec 10. Chemotherapy. 2008. PMID: 18073472 Clinical Trial.

9

A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome.

Kim H, Min YJ, Baek JH, Shin SJ, Lee EH, Noh EK, Kim MY, Park JH. Kim H, et al. Among authors: min yj. Leuk Res. 2009 Feb;33(2):222-31. doi: 10.1016/j.leukres.2008.08.004. Epub 2008 Sep 14. Leuk Res. 2009. PMID: 18790532 Clinical Trial.

10

Gefitinib enhances arsenic trioxide (AS2O3)-induced differentiation of acute promyelocytic leukemia cell line.

Noh EK, Kim H, Park MJ, Baek JH, Park JH, Cha SJ, Won JH, Min YJ. Noh EK, et al. Among authors: min yj. Leuk Res. 2010 Nov;34(11):1501-5. doi: 10.1016/j.leukres.2010.02.016. Epub 2010 Mar 11. Leuk Res. 2010. PMID: 20226526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters